Biocryst Pharmaceuticals Inc.
BCRX
Market Cap$2.11B
Close$
$7.62
21.2% downside
Current Fair Value
21.2% downsideOvervalued by 21.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.11 Billion |
|---|---|
| Enterprise Value | $1.80 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.43 |
| Beta | 1.1 |
| Outstanding Shares | 208,882,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -39.46 |
|---|---|
| PEG | 39.42 |
| Price to Sales | 4.83 |
| Price to Book Ratio | 4.83 |
| Enterprise Value to Revenue | 3.57 |
| Enterprise Value to EBIT | -229.75 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biocryst Pharmaceuticals Inc.
CEO: Jon Stonehouse